Table 1. Demographic Information and Baseline Clinical Data in SCLC Patients.
| Parameter | Value/cases |
|---|---|
| Age | |
| Median (yr) | 53 |
| Range (yr) | 36-75 |
| Male/female (n/n) | 60/29 |
| Anatomic stage (n) | |
| I | 12 |
| II | 19 |
| III | 52 |
| IV | 4 |
| VALSG stage (n) | |
| Limited | 87 |
| Extensive | 2 |
| Recurrence (n) | |
| Yes | 13 |
| No | 76 |
| Neoadjuvant chemotherapy (n) | |
| Yes | 20 |
| No | 69 |
SCLC, small cell lung cancer; VALSG, Veteran's Administration Lung Study Group.
The corresponding TNM classifications for each anatomic stage were as follows: stage I: T1aN0M0, T1bN0M0, and T2aN0M0, stage II: T1aN1M0, T1b-N1M0, T2aN1M0, T2bN0M0, T2bN1M0, and T3N0M0, stage III: T1N2M0, T2N2M0, T3N1M0, T3N2M0, T4N0M0, T4N1M0, T4N2M0, T1N3M0, T2N3M0, T3N3M0, and T4N3M0, stage IV: T any, N any, and M1a or 1b.